Gastric Neuroendocrine Tumors in Our Institutions According to the WHO 2010 Classification

被引：16

作者：

Endo, Shunji ^{[1
,3
]}

Dousei, Tsutomu ^{[1
]}

Yoshikawa, Yukinobu ^{[3
]}

Hatanaka, Nobutaka ^{[3
]}

Taniyama, Kiyomi ^{[4
]}

Yamauchi, Amane ^{[2
]}

Kamiike, Wataru ^{[3
]}

Nishijima, Junichi ^{[1
]}

机构：

[1] Higashiosaka City Gen Hosp, Dept Surg, Higashiosaka, Osaka 5788588, Japan

[2] Higashiosaka City Gen Hosp, Dept Diagnost Pathol, Higashiosaka, Osaka 5788588, Japan

[3] Natl Hosp Org, Kure Med Ctr, Chugoku Canc Ctr, Dept Surg, Kure, Hiroshima, Japan

[4] Natl Hosp Org, Kure Med Ctr, Chugoku Canc Ctr, Inst Clin Res, Kure, Hiroshima, Japan

来源：

INTERNATIONAL SURGERY | 2012年 / 97卷 / 04期

关键词：

Stomach neoplasms; Neuroendocrine tumors; Carcinoid tumor; Neuroendocrine carcinoma; Small cell carcinoma; Gastrin; Mitosis; Ki-67; antigen; Gastrectomy; World Health Organization; GUIDELINES; CARCINOMA; STOMACH;

D O I：

10.9738/CC134.1

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

In 2010, World Health Organization classified gastric neuroendocrine tumor (NET) as follows: NET grade (G) 1, NET G2, neuroendocrine carcinoma (NEC). We reviewed 22 gastric NETs that were encountered in our institutions. Nine, 6, and 4 were NET G1, G2, and NEC, respectively. We also encountered 3 NET G3. NET G1 was treated with observation in 2 patients, endoscopic mucosal resection (EMR) in 3, and gastrectomy in 4 patients. No recurrence was experienced during a median of 53 months of follow-up. All NET G2 was treated with gastrectomy. No patient experienced recurrence during a median of 25 months of follow-up. NET G3 was treated with gastrectomy. One patient died of liver metastasis 52 months after gastrectomy. For NEC, gastrectomy was performed in 3 cases and no patients died of tumor-related death. We conclude that the prognoses of NET G1 and G2 were good. We also experienced long-term survivors of NEC. An accumulation of more patients is needed for further investigation.

引用

页码：335 / 339

页数：5

共 8 条

[1] NANETS Treatment Guidelines Well-Differentiated Neuroendocrine Tumors of the Stomach and Pancreas [J].

Kulke, Matthew H. ;

Anthony, Lowell B. ;

Bushnell, David L. ;

de Herder, Wouter W. ;

Goldsmith, Stanley J. ;

Klimstra, David S. ;

Marx, Stephen J. ;

Pasieka, Janice L. ;

Pommier, Rodney F. ;

Yao, James C. ;

Jensen, Robert T. .

PANCREAS, 2010, 39 (06) :735-752

[2]

*NAT COMPR CANC NE, NCCN GUID VERS 1 201

[3] 3 SUBTYPES OF GASTRIC ARGYROPHIL CARCINOID AND THE GASTRIC NEUROENDOCRINE CARCINOMA - A CLINICOPATHOLOGICAL STUDY [J].

RINDI, G ;

LUINETTI, O ;

CORNAGGIA, M ;

CAPELLA, C ;

SOLCIA, E .

GASTROENTEROLOGY, 1993, 104 (04) :994-1006

[4] ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: Prognostic evaluation by pathological analysis [J].

Rindi, G ;

Azzoni, C ;

La Rosa, S ;

Klersy, C ;

Paolotti, D ;

Rappel, S ;

Stolte, M ;

Capella, C ;

Bordi, C ;

Solcia, E .

GASTROENTEROLOGY, 1999, 116 (03) :532-542

[5]

Rindi G., 2010, WHO classification of tumors of the digestive system

[6]

Sobin LH., 2011, TNM classification of malignant tumours

[7]

Solcia E, 2000, HISTOLOGICAL TYPING OF ENDOCRINE TUMOURS, 2ND EDITION, P61

[8] The NANETS Consensus Guidelines for the Diagnosis and Management of Poorly Differentiated (High-Grade) Extrapulmonary Neuroendocrine Carcinomas [J].

Strosberg, Jonathan R. ;

Coppola, Domenico ;

Klimstra, David S. ;

Phan, Alexandria T. ;

Kulke, Matthew H. ;

Wiseman, Gregory A. ;

Kvols, Larry K. .

PANCREAS, 2010, 39 (06) :799-800

← 1 →